Johnson & Johnson's Official Statement in Response to Today's Verdict in St. Louis Trial
PR Newswire
NEW BRUNSWICK, N.J., July 12, 2018
NEW BRUNSWICK, N.J., July 12, 2018 /PRNewswire/ -- Johnson & Johnson JNJ issued the following statement regarding today's verdict in the St. Louis court.
"Johnson & Johnson is deeply disappointed in the verdict, which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer. The result of the verdict, which awarded the exact same amounts to all plaintiffs irrespective of their individual facts, and differences in applicable law, reflects that the evidence in the case was simply overwhelmed by the prejudice of this type of proceeding. Johnson & Johnson remains confident that its products do not contain asbestos and do not cause ovarian cancer and intends to pursue all available appellate remedies. Every verdict against Johnson & Johnson in this court that has gone through the appeals process has been reversed and the multiple errors present in this trial were worse than those in the prior trials which have been reversed."
View original content with multimedia:http://www.prnewswire.com/news-releases/johnson--johnsons-official-statement-in-response-to-todays-verdict-in-st-louis-trial-300680519.html
SOURCE Johnson & Johnson
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.